The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and Treatment Resource Center. This center will be an ongoing, patient-centered quality improvement initiative focused on helping increase peripheral artery disease (PAD) awareness in the cardiovascular and internal medicine community by delving into the underlying risks of this disease state.
May 14, 2018
May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total ...
May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients ...
May 14, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | SCAI
Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular ...
May 14, 2018
News | Cardiovascular Business
May 14, 2018 — Diagnostic and Interventional Cardiology (DAIC) magazine was honored with a Silver national Azbee Award ...
May 14, 2018News | Heart Failure
Ancora Heart Inc. announced the expansion of the company’s U.S. feasibility study to evaluate the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation (FMR). Ancora has received approval from the U.S. Food and Drug Administration (FDA) to enroll a second group of subjects and expand to 15 heart centers across the United States.
May 14, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Heart Valve Technology
A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in patients undergoing transcatheter aortic valve replacement (TAVR). This first-ever tool calculates a score to help clinicians and medical professionals predict risk of 30-day readmission for TAVR patients and can be easily incorporated in patient electronic medical records (EMR). The study was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions, April 25-28 in San Diego.
May 11, 2018
News | Pulmonary Embolism
Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions, April 25-28 in San Diego. The FLARE study is a prospective, single-arm multicenter trial designed to evaluate the safety and efficacy of the Flowtriever system (Inari Medical, Irvine, Calif.) in patients with acute pulmonary embolism (PE). It is the first trial to treat pulmonary embolism without using thrombolytics, the use of drugs to break up or dissolve blood clots that can lead to bleeding complications.
May 11, 2018
News
May 11, 2018 — Two studies examining seasonal variations in cardiac-related hospitalizations, specifically for aortic ...
May 11, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Heart Valve Technology
Medtronic plc announced two-year outcomes for the Harmony Transcatheter Pulmonary Valve (TPV) from its early feasibility study at the Society for Cardiovascular Angiography and Interventions (SCAI) 41st Annual Scientific Sessions, April 25-28 in San Diego. Data from 18 patients followed out to two years revealed the Harmony TPV showed solid valve function and no paravalvular leak (PVL).
May 11, 2018
Technology | Artificial Intelligence
EnvoyAI announced a new integration with Insignia Medical Systems’ InSight PACS (picture archiving and communication system) to provide artificial intelligence (AI)-enhanced imaging workflows to customers. For initial launch in the U.K., this integration provides curated AI content available on the EnvoyAI platform within the PACS environment at multiple integration points. These include AI results viewing directly within the PACS viewer, as well as within the already established Insignia integration with TeraRecon.
May 11, 2018
News | Structural Heart
May 11, 2018 — The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial ...
May 11, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Heart Failure
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure. This effect is similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.
May 11, 2018
News | Atrial Fibrillation
A new study finds that integrating two separate clinical risk score models more accurately helps clinicians assess the stroke risk of patients with atrial fibrillation (Afib).
May 11, 2018
News | Vascular Closure Devices
Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the company’s AMBULATE series. The AMBULATE series is studying the Vascade MVP Venous Vascular Closure System for use in the closure of mid-bore (6-12 Fr inner diameter sheath) venous access sites.
May 10, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now